Top startup acquisitions · Healthtech & bio
Top Healthtech & bio startup acquisitions in April 2026
We tracked 8 startup exits in April 2026. 4 disclosed a price, worth $11.05bn in total. The biggest was Eli Lilly buying Kelonia Therapeutics for $7bn, ahead of Eli Lilly and Ajax Therapeutics at $2.3bn.
All Healthtech & bio startup acquisitions →- Eli Lilly → Kelonia TherapeuticsHealthtech & bioBoston, United States$7bn$1bn+
- Eli Lilly → Ajax TherapeuticsHealthtech & bioNew York, United States$2.3bn$1bn+
- UCB → Neurona TherapeuticsHealthtech & bioSouth San Francisco, United States$1.15bn$1bn+
- Foundation Medicine → SAGA DiagnosticsHealthtech & bioResearch Triangle Park, United States$595m$250m–1bn
- Azra AI → Thynk HealthHealthtech & bioLexington, United StatesUndisclosedUndisclosed
- ModMed → Bonsai HealthHealthtech & bioUnited StatesUndisclosedUndisclosed
- TELCOR → Sample HealthcareHealthtech & bioUnited StatesUndisclosedUndisclosed
- Koltin → Last Mile CareHealthtech & bioMexicoUndisclosedUndisclosed